Cancer survivors are more than twice as likely to have problems with insomnia than the average adult. If left untreated, insomnia is associated with a broad range of medical and psychosocial consequences, including mortality. The cognitive-behavioral treatment of insomnia has been proven for decades to be the most effective treatment, but is rarely available in cancer populations because of poor screening practices and a limited supply of trained providers. Dr. Zhou will discuss his efforts to better understand insomnia in cancer populations, to adapt conventional treatment methods to improve treatment accessibility, and to consider intervention translation into public health settings.
Speaker: Eric Zhou, PhD., Psychologist, Dana-Farber Cancer Institute and Instructor, Harvard Medical School
695 Park Avenue
Psychology Seminar Room, Room 611HN
New York, NY 10065